126 related articles for article (PubMed ID: 34611965)
1. Cycle-network expansion plan in Oslo: Modeling cost-effectiveness analysis and health equity impact.
Lamu AN; Norheim OF; Gregersen FA; Barra M
Health Econ; 2021 Dec; 30(12):3220-3235. PubMed ID: 34611965
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
Kowal S; Ng CD; Schuldt R; Sheinson D; Cookson R
Value Health; 2023 Feb; 26(2):216-225. PubMed ID: 36192293
[TBL] [Abstract][Full Text] [Related]
3. Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact.
Laxy M; Zhang P; Ng BP; Shao H; Ali MK; Albright A; Gregg EW
Appl Health Econ Health Policy; 2020 Oct; 18(5):713-726. PubMed ID: 32607728
[TBL] [Abstract][Full Text] [Related]
4. Is cycle network expansion cost-effective? A health economic evaluation of cycling in Oslo.
Lamu AN; Jbaily A; Verguet S; Robberstad B; Norheim OF
BMC Public Health; 2020 Dec; 20(1):1869. PubMed ID: 33287754
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
[TBL] [Abstract][Full Text] [Related]
6. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
Marklund M; Zheng M; Veerman JL; Wu JHY
PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
[TBL] [Abstract][Full Text] [Related]
7. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
8. Five-year cost-effectiveness analysis of the European Fans in Training (EuroFIT) physical activity intervention for men versus no intervention.
Kolovos S; Finch AP; van der Ploeg HP; van Nassau F; Broulikova HM; Baka A; Treweek S; Gray CM; Jelsma JGM; Bunn C; Roberts GC; Silva MN; Gill JMR; Røynesdal Ø; van Mechelen W; Andersen E; Hunt K; Wyke S; Bosmans JE
Int J Behav Nutr Phys Act; 2020 Mar; 17(1):30. PubMed ID: 32131849
[TBL] [Abstract][Full Text] [Related]
9. Distributional impact of infectious disease interventions in the Ethiopian Essential Health Service Package: a modelling study.
Assebe LF; Norheim O
BMJ Open; 2023 Jul; 13(7):e067658. PubMed ID: 37460265
[TBL] [Abstract][Full Text] [Related]
10. Reducing regional health inequality: a sub-national distributional cost-effectiveness analysis of community-based treatment of childhood pneumonia in Ethiopia.
Olsen M; Norheim OF; Memirie ST
Int J Equity Health; 2021 Jan; 20(1):9. PubMed ID: 33407559
[TBL] [Abstract][Full Text] [Related]
11. Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK.
Kypridemos C; Collins B; McHale P; Bromley H; Parvulescu P; Capewell S; O'Flaherty M
PLoS Med; 2018 May; 15(5):e1002573. PubMed ID: 29813056
[TBL] [Abstract][Full Text] [Related]
12. Equity Weights for Socioeconomic Position: Two Methods-Survey of Stated Preferences and Epidemiological Data.
Lal A; Mohebi M; Sweeney R; Moodie M; Peeters A; Carter R
Value Health; 2019 Feb; 22(2):247-253. PubMed ID: 30711071
[TBL] [Abstract][Full Text] [Related]
13. A publicly well-accepted measure versus an academically desirable measure of health inequality: cross-sectional comparison of the difference between income quintiles with the slope index of inequality.
Khang YH; Lim D; Bahk J; Kim I; Kang HY; Chang Y; Jung-Choi K
BMJ Open; 2019 Jun; 9(6):e028687. PubMed ID: 31248930
[TBL] [Abstract][Full Text] [Related]
14. Social and material deprivation and the cost-effectiveness of an intervention to promote physical activity: cohort study and Markov model.
Gulliford M; Charlton J; Bhattarai N; Rudisill C
J Public Health (Oxf); 2014 Dec; 36(4):674-83. PubMed ID: 24482061
[TBL] [Abstract][Full Text] [Related]
15. Incorporating equity-efficiency interactions in cost-effectiveness analysis-three approaches applied to breast cancer control.
Baeten SA; Baltussen RM; Uyl-de Groot CA; Bridges J; Niessen LW
Value Health; 2010 Aug; 13(5):573-9. PubMed ID: 20384980
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
[TBL] [Abstract][Full Text] [Related]
17. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
[TBL] [Abstract][Full Text] [Related]
18. Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.
Love-Koh J; Cookson R; Gutacker N; Patton T; Griffin S
Value Health; 2019 May; 22(5):518-526. PubMed ID: 31104729
[TBL] [Abstract][Full Text] [Related]
19. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
20. Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: A cost-effectiveness and equity analysis.
Lal A; Mantilla-Herrera AM; Veerman L; Backholer K; Sacks G; Moodie M; Siahpush M; Carter R; Peeters A
PLoS Med; 2017 Jun; 14(6):e1002326. PubMed ID: 28654688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
